SCHEMBL12922020

SCHEMBL12922020

ClCCNCCNCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1311496 0.86 LMNA (0.38)
Hydrochloric Acid SCHEMBL9008650 0.82 KDM4E (0.41)
Nornitrogen Mustard SCHEMBL24674 0.82
SCHEMBL722930 0.78
Nornitrogen Mustard SCHEMBL2064862 0.78
Nornitrogen Mustard SCHEMBL246133 0.78
Nornitrogen Mustard SCHEMBL1332213 0.78
Hydrochloric Acid SCHEMBL3861975 0.74
Nornitrogen Mustard SCHEMBL14636056 0.74
SCHEMBL2571537 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879861-B2 4-N-(3-bromophenyl)-6-N-(2-chloroethyl)quinazoline-4,6-diamine, capable of both inhibiting epidermal growth factor receptors and damaging DNA; antitumor and antiproliferative agents MCGILL UNIVERSITY (CA) 2011-02-01 US disclosed